Antibody and markers of T-cell activation illuminate the pathogenesis of HCV immune restoration disease in HIV/HCV co-infected patients commencing ART

QR Code

Antibody and markers of T-cell activation illuminate the pathogenesis of HCV immune restoration disease in HIV/HCV co-infected patients commencing ART

Some HIV/hepatitis C virus co-infected patients beginning ART experience Immune Restoration Disease (IRD) manifested as a rise in serum alanine transaminase. This was investigated in HIV/HCV co-infected individuals (n = 50) commencing ART in Jakarta (Indonesia). Samples were collected at weeks 0, 4,...

Full description

Bibliographic Details
Main Authors:	Yunihastuti, E., Lee, S., Gani, R., Saraswati, H., Sundaru, H., Lesmana, L., Sukmana, N., Price, Patricia
Format:	Journal Article
Published:	Academic Press Inc. 2011
Online Access:	http://hdl.handle.net/20.500.11937/45675

Similar Items

Patients co-infected with hepatitis C virus (HCV) and human immunodeficiency virus recover genotype cross-reactive neutralising antibodies to HCV during antiretroviral therapy
by: Lee, S., et al.
Published: (2014)

Few Liver-Infiltrating Cells Express CXCR3 in HIV/HCV Patients Commencing Antiretroviral Therapy.
by: Marini, S., et al.
Published: (2016)

The dynamics of HCV-specific antibody responses in HIV/HCV patients on long-term antiretroviral therapy
by: Lee, S., et al.
Published: (2017)

Increased proportions of dendritic cells and recovery of IFNγ responses in HIV/HCV co-infected patients receiving ART
by: Saraswati, H., et al.
Published: (2015)

Detection of HCV-specific IFN-gamma responses in HCV antibody and HCV RNA negative injecting drug users
by: Flynn, J., et al.
Published: (2014)

Periportal CD4+ Cell Infiltration Increases in HIV/Hepatitis C Virus–Coinfected Patients Commencing ART, Whereas CD8+ Cells Clear From the Liver
by: Gani, R., et al.
Published: (2014)

Mycobacterial antibody levels and immune restoration disease in HIV patients treated in South East Asia
by: Sumatoh, H., et al.
Published: (2011)

Experimental design of a novel target to isolate HCV monoclonal antibodies
by: Brice, Sophie
Published: (2014)

Biodynamics of HCV infection in haemodialysis patients in Pahang
by: Mustafa Mahmoud, Mohammed Imad Al-Deen, et al.
Published: (2011)

Biodynamics of HCV infection in haemodialysis patients in Pahang
by: Mustafa Mahmoud, Mohammed Imad Al-Deen, et al.
Published: (2010)

Could a loss of memory T cells limit responses to hepatitis C virus (HCV) antigens in blood leucocytes from patients chronically infected with HCV before and during pegylated interferon-a and ribavirin therapy?
by: Lee, S., et al.
Published: (2010)

HCV genotypes in haemodialysis units: a preliminary study
by: Hamzah, Hairul Aini, et al.
Published: (2008)

HCV, Iron, and Oxidative Stress: The New Choreography of Hepcidin
by: Trinder, D., et al.
Published: (2008)

Hepatitis C virus (HCV) diagnosis via microfluidics
by: Narayanamurthy, Vigneswaran, et al.
Published: (2021)

Assessment of Cox2 and CMV in patients with chronic HCV infection
by: F. Hassan, Heba, et al.
Published: (2017)

Immune restoration disease complicating antiretroviral therapy in patients with HIV infection: Implications and solutions
by: French, M., et al.
Published: (2008)

Development of ELISA method for primary detection of HCV using core antigen
by: Nourollahi, Shirin, et al.
Published: (2011)

Immune responses to hepatitis C virus (HCV): investigation of the role of L-ficolin and anti-E1E2
by: Hamed, Mohamed R.
Published: (2009)

Naive and Memory CD4+ T Cells Are Differentially Affected in Indonesian HIV Patients Responding to ART
by: Tanaskovic, S., et al.
Published: (2016)

Characterization of occult hepatitis c virus (hcv) infection among hemodialysis patient
by: Abdul Rahman, Siti Nurul Fazlin, et al.
Published: (2017)

Cohort profile: the Hepatitis C Virus (HCV) Research UK clinical database and biobank
by: McLauchlan, John, et al.
Published: (2017)

The search for biomarkers of immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
by: Oliver, B., et al.
Published: (2011)

Identification of residues involved in NS2 homodimerization and elucidation of their impact on the HCV life cycle
by: Gorzin, A., et al.
Published: (2012)

The role of blood transfusion in HCV infection: a study testing Ab: RNA & genotype
by: Waqar A. Al-Kubaisy,
Published: (2011)

CD56+ lymphocyte counts remain low in the livers of human immunodeficiency virus/hepatitis C virus patients commencing ART
by: Susufi, Y., et al.
Published: (2015)

Characteristics of natural killer cells in Malaysian HIV patients presenting with immune restoration disease after ART
by: Tan, D., et al.
Published: (2010)

Increased proportion of the CD56bright NK cell subset in patients chronically infected with Hepatitis C Virus (HCV) receiving interferon-a and ribavirin therapy
by: Lee, S., et al.
Published: (2010)

Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy
by: Khera, Tanvi, et al.
Published: (2017)

Active and Persistent Cytomegalovirus Infections Affect T Cells in Young Adult HIV Patients Commencing Antiretroviral Therapy
by: Ariyanto, I., et al.
Published: (2018)

Mycobacterial immune restoration disease: One symphony, two or many?
by: Price, Patricia
Published: (2012)

Establishment of simultaneous detection and quantitation of HCV-RNA by third generation intercalating dye real-time PCR
by: M. Saleh Habil, Akrahm, et al.
Published: (2018)

The Potential Reach of Opioid Substitution Settings to Deliver HCV Care to People Who Inject Drugs in Australia
by: Butler, K., et al.
Published: (2015)

Endogenous IFNγ in chronic HCV genotype 4 patients treated with PEG-IFNα and ribavirin
by: Sadeq, Refat, et al.
Published: (2013)

The search for a genetic factor associating with immune restoration disease in HIV patients co-infected with Mycobacterium tuberculosis
by: Affandi, J., et al.
Published: (2013)

Pre-antiretroviral therapy plasma levels of CCL2 may aid in the prediction of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV patients after they commence antiretroviral therapy
by: Oliver, B., et al.
Published: (2013)

Seroprevalence study of HCV Genotypes in two tertiary hospital and its association with risk factors and current management practice
by: Hasmoni, Mohamed Hadzri, et al.
Published: (2009)

Development of HCV genotyping protocol based on high resolution melting analysis real-time PCR: a pilot study
by: Hamzah, Hairul Aini
Published: (2017)

A study of the natural history of hepatitis C infection within a geographically determined population (Trent HCV study)
by: Lawson, Adam
Published: (2012)

In-house semi-nested reverse transcription polymerase chain reaction for the detection of HCV-RNA in serum with low viral load
by: Hamzah, Hairul Aini, et al.
Published: (2013)

Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
by: Oliver, B., et al.
Published: (2010)